On December 8, 2025, Bernstein maintained coverage of Strategy (NasdaqGS:MSTR) with an Outperform recommendation, projecting a 200.23% upside with an average one-year price target of $537.38/share. The projected annual revenue is 561MM with a non-GAAP EPS of 1.07. There are 1,591 funds or institutions reporting positions in Strategy, with an increase in total shares owned by institutions over the last three months.
Major shareholders like Capital International Investors, AGTHX – Growth Fund of America, VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, Clear Street, and Invesco Qqq Trust, Series 1 have all increased their portfolio allocations in MSTR over the last quarter. The put/call ratio of MSTR is 0.78, indicating a bullish outlook on the stock.
Fintel provides comprehensive investing research for individual investors, traders, financial advisors, and small hedge funds. Their data includes fundamentals, analyst reports, ownership data, fund sentiment, insider trading, options sentiment, and more. Exclusive stock picks are powered by advanced quantitative models for improved profits. Learn more on Fintel’s platform.
Read more at Nasdaq.: Bernstein Maintains Strategy (MSTR) Outperform Recommendation
